Some individuals notice reduced appetite within the first week, but meaningful weight loss typically becomes apparent after 4 to 8 weeks of treatment
These findings highlight the broader physiological significance of GIP signaling and support the rationale for its therapeutic targeting in dual agonist agents such as tirzepatide
Nieto LM, Martinez J, Narvaez SI, et al
The patient is the key, he says
Once youve benefited from the weight loss assistance of a GLP-1, a transition to lifestyle-based weight maintenance may be the right move
Why GLP-1 drugs and menopause could create a perfect storm for bone loss Bone loss can lead to osteoporosis, which causes bones to become porous, weaker and brittle, making them more likely to break, often in the hips, spine and wrists